Use of sorbitol as pharmaceutical excipient in the present day formulations – issues and challenges for drug absorption and bioavailability

References

• Livesey G. Health potential of polyols as sugar replacers, with emphasis on low-glycaemic properties. Nutr Res Rev. 2003;16:163–191.
   PubMed Web of Science ®Google Scholar
• Shankar P, Ahuja S, Sriram K. Non-nutritive sweeteners: review and update. Nutrition. 2013;29:1293–1299.
   PubMed Web of Science ®Google Scholar
• Ortiz ME, Bleckwedel J, Raya RR, et al. Biotechnological and in situ food production of polyols by lactic acid bacteria. Appl Microbiol Biotechnol. 2013;97:4713–4726.
   PubMed Web of Science ®Google Scholar
• Evrendilek GA. Sugar alcohols (polyols). In: Varzakas T, Labropoulos A, Anestis S, editors. Sweeteners: nutritional aspects, applications, and production technology. Boca Raton (FL): CRC Press; 2012. p. 45–47.
   Google Scholar
• Akinterinwa O, Khankal R, Cirino PC. Metabolic engineering for bioproduction of sugar alcohols. Curr Opin Biotechnol. 2008;19:461–467.
   PubMed Web of Science ®Google Scholar
• Silveira M, Jonas R. The biotechnological production of sorbitol. Appl Microbiol Biotechnol. 2002;59:400–408.
   PubMed Web of Science ®Google Scholar
• Regulation (EC) no. 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives [cited 2019 May 20]. http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:354:0016:0033:en:PDF
   Google Scholar
• Mortensen A. Sweeteners permitted in the European Union: safety aspects. Scand J Food Nutr. 2006;50:104–116.
   Google Scholar
• EFSA. Scientific opinion on the substantiation of health claims related to the sugar replacers xylitol, D-tagatose, xylitol, sorbitol, mannitol, maltitol, lactitol, isomalt, erythritol, D-tagatose, isomaltulose, sucralose and polydextrose and maintenance of tooth mineralisation by decreasing tooth demineralisation. EFSA J. 2011;9:2076.
   Google Scholar
• Sorbitol SJ. 2009. In: Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients. London: Pharmaceutical Press; p. 679–682.
   Google Scholar
• Niazi SK. Handbook of pharmaceutical manufacturing formulations, liquid products, Vol. 3. New York: CRC Press; 2009.
   Google Scholar
• Niazi SK. Handbook of pharmaceutical manufacturing formulations, compressed solid products, Vol. 1. New York: CRC Press; 2009.
   Google Scholar
• Basedow AM, Möschl GA, Schmidt PC. Sorbitol instant an excipient with unique tableting properties. Drug Dev Ind Pharm. 1986;12:2061–2089.
   Web of Science ®Google Scholar
• Ciper M, Bodmeier R. Preparation and characterization of novel fast disintegrating capsules (Fastcaps) for administration in the oral cavity. Int J Pharm. 2005;303:62–71.
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Nokhodchi A, Qarakhani N, et al. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit® E100. Drug Dev Ind Pharm. 2004;30:303–317.
   PubMed Web of Science ®Google Scholar
• Bakaltcheva I, O'Sullivan AM, Hmel P, et al. Freeze-dried whole plasma: evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers. Thromb Res. 2007;120:105–116.
   PubMed Web of Science ®Google Scholar
• Feng-Iai T. Application of sorbitol in cosmetics. China surfactant detergent & cosmetics. Riyong Huaxue Gongye; 1990. p. 63–68.
   Google Scholar
• Volicer L, Lane P, Panke J, et al. Management of constipation in residents with dementia: Sorbitol effectiveness and cost. J Am Med Dir Assoc. 2005;6:S32–S34.
   PubMedGoogle Scholar
• Hill DB, Henderson LM, Mcclain CJ. Osmotic diarrhea induced by sugar‐free theophylline solution in critically III patients. J Parenter Enteral Nutr. 1991;15:332–336.
   PubMed Web of Science ®Google Scholar
• Ward N. The impact of intestinal failure on oral drug absorption: a review. J Gastrointest Surg. 2010;14:1045–1051.
   PubMed Web of Science ®Google Scholar
• EPIVIR [package insert]. Research Triangle Park, NC: ViiV Healthcare; 2016.
   Google Scholar
• Strauch S, Jantratid E, Dressman JB, et al. Biowaiver monographs for immediate release solid oral dosage forms: lamivudine. J Pharm Sci. 2011;100:2054–2063.
   PubMed Web of Science ®Google Scholar
• Yuen GJ, Morris DM, Mydlow PK, et al. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. J Clin Pharmacol. 1995;35:1174–1180.
   PubMed Web of Science ®Google Scholar
• Kasirye P, Kendall L, Adkison KK, et al. Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1. Clin Pharmacol Ther. 2012;91:272–280.
   PubMed Web of Science ®Google Scholar
• Adkison K, Wolstenholme A, Lou Y, et al. Effect of sorbitol on the pharmacokinetic profile of lamivudine oral solution in adults: an open-label, randomized study. Clin Pharmacol Ther. 2018;103:402–408.
   PubMed Web of Science ®Google Scholar
• Chen ML, Straughn AB, Sadrieh N, et al. A modern view of excipient effects on bioequivalence: case study of sorbitol. Pharm Res. 2007;24:73–80.
   PubMed Web of Science ®Google Scholar
• Al-Shareef AH, Buss DC, Allen EM, et al. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Hum Exp Toxicol. 1990;9:179–182.
   PubMed Web of Science ®Google Scholar
• Berg MJ, Rose JQ, Wurster DE, et al. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital. Ther Drug Monit. 1987;9:41–47.
   PubMed Web of Science ®Google Scholar
• van Os S, Relleke M, Piniella PM. Lack of bioequivalence between generic risperidone oral solution and originator risperidone tablets. Int J Clin Pharmacol Ther. 2007;45:293–299.
   PubMed Web of Science ®Google Scholar
• Vaithianathan S, Haidar SH, Zhang X, et al. Effect of common excipients on the oral drug absorption of biopharmaceutics classification system class 3 drugs cimetidine and acyclovir. J Pharm Sci. 2016;105:996–1005.
   PubMed Web of Science ®Google Scholar
• Grant SM, Langtry HD, Brogden RN. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs. 1989;37:801–870.
   PubMed Web of Science ®Google Scholar
• Grammatte T, Desoky EE, Klotz U. Site-dependent small intestinal absorption of ranitidine. Eur J Clin Pharmacol. 1994;46:253Y259.
   Web of Science ®Google Scholar
• Di Nicolantonio JJ, Fares H, Niazi AK, et al. β-blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart. 2015;2:e000230.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med. 2003;167:813–818.
   PubMed Web of Science ®Google Scholar
• Fassihi AR, Dowse R, Robertson S. Influence of sorbitol solution on the bioavailability of theophylline. Int J Pharm. 1991;72:175–178.
   Google Scholar
• El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med. 2017;22:321–327.
   PubMed Web of Science ®Google Scholar
• Cooney DO. Activated charcoal: antidotal and other medicinal uses. New York: Marcel Dekker; 1980.
   Google Scholar
• Goldberg MJ, Berlinger WG, Park GD. Activated charcoal in phenobarbital overdose. JAMA. 1985;253:1120–1121.
   PubMed Web of Science ®Google Scholar
• Chyka PA, Erdman AR, Christianson G, et al. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45:95–131.
   PubMed Web of Science ®Google Scholar
• Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med. 1990;19:654–656.
   PubMed Web of Science ®Google Scholar
• Möller HJ. Risperidone: a review. Expert Opin Pharmacother. 2005;6:803–818.
   PubMed Web of Science ®Google Scholar
• Webster J, Barber HE, Hawksworth GM, et al. Cimetidine-a clinical and pharmacokinetic study. Br J Clin Pharmacol. 1981;11:333–338.
   PubMed Web of Science ®Google Scholar
• Gnann JW Jr, Barton NH, Whitley RJ. Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy. 1983;3:275–283.
   PubMed Web of Science ®Google Scholar
• Carrasco EO, Jose FR, Samson GD, et al. Effect of D-sorbitol on the absorption and transfer of nutrients from mother to fetus. Am J Clin Nutr. 1962;11:533–536.
   PubMed Web of Science ®Google Scholar
• Chalmers JN, Shinton NK. Effect of D-sorbitol on the absorption of orally administered vitamin B12. Nature. 1959;183:120–121.
   PubMed Web of Science ®Google Scholar
• Chow BF, Prystowsky H, Hellegers AE, et al. Studies on the absorption of vitamin B12 in human pregnancy with especial reference to the effect of D-sorbitol. Am J Obstet Gynecol. 1958;76:91–95.
   PubMed Web of Science ®Google Scholar
• Adkin DA, Davis SS, Sparrow RA, et al. The effects of pharmaceutical excipients on small intestinal transit. Br J Clin Pharmacol. 1995;39:381–387.
   PubMed Web of Science ®Google Scholar
• Williams MF, Dukes GE, Heizer W, et al. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm Res. 1992;9:1190–1194.
   PubMed Web of Science ®Google Scholar
• García-Arieta A, Gordon J, Potthast H. On the effect of common excipients on the oral absorption of class 3 drugs. J Pharm Sci. 2016;105:1353–1354.
   PubMed Web of Science ®Google Scholar
• García-Arieta A. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence. Eur J Pharm Sci. 2014;65:89–97.
   PubMed Web of Science ®Google Scholar
• Koenigshof AM, Beal MW, Poppenga RH, et al. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs. J Vet Emerg Crit Care. 2015;25:606–610.
   PubMed Web of Science ®Google Scholar